Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-weekly Versus Daily Injectable Glucagon-like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)
mediaposted on 17.12.2021, 15:28 by Adis Journals on Behalf of, William H. Polonsky, Riya Arora, Mads Faurby, João Fernandes, Andreas Liebl
The above Graphical Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.